Evidence map›Paper›PMID 32297489›Full record

ArticleJournal of biomedical optics2020

High-power light-emitting diode array design and assembly for practical photodynamic therapy research.

Eric M Kercher, Kai Zhang, Matt Waguespack, Ryan T Lang, Alejandro Olmos, Bryan Q Spring

Open access · goldAbstract read
In one paragraph

Article in Journal of biomedical optics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.3field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Eric M KercherNortheastern University, Translational Biophotonics Cluster, Boston, Massachusetts, United States.
Kai ZhangNortheastern University, Translational Biophotonics Cluster, Boston, Massachusetts, United States.
Matt WaguespackNortheastern University, Translational Biophotonics Cluster, Boston, Massachusetts, United States.
Ryan T LangNortheastern University, Translational Biophotonics Cluster, Boston, Massachusetts, United States.
Alejandro OlmosNortheastern University, Department of Health Sciences, Boston, Massachusetts, United States.
Bryan Q SpringNortheastern University, Translational Biophotonics Cluster, Boston, Massachusetts, United States.

Funding

Online monitoring and image-guided treatment of chemoresistant micrometastasesK22CA181611 · NCI · NORTHEASTERN UNIVERSITY · PI SPRING, BRYAN QUILTY · 2015 to 2017
$559k
NCI NIH HHS K22 CA181611
6 · The paper itself

Abstract

significanceCommercial lasers, lamps, and light-emitting diode (LED) light sources have stimulated the clinical translation of photodynamic therapy (PDT). Yet, the continued exploration of new photosensitizers (PSs) for PDT often requires separate activation wavelengths for each agent being investigated. Customized light sources for such research frequently come at significant financial or technical cost, especially when compounded over many agents and wavelengths.

aimLEDs offer potential as a cost-effective tool for new PS and multi-PS photodynamic research. A low-cost-per-wavelength tool leveraging high-power LEDs to facilitate efficient and versatile research is needed to further accelerate research in the field. APPROACH: We developed and validated a high-power LED array system for benchtop PDT with a modular design for efficient switching between wavelengths that overcome many challenges in light source design. We describe the assembly of a low-cost LED module plus the supporting infrastructure, software, and protocols to streamline typical in vitro PDT experimentation.

resultsThe LED array system is stable at intensities in excess of 100  mW  /  cm2 with 2.3% variation across the illumination field, competitive with other custom and commercial devices. To demonstrate efficacy and versatility, a primary ovarian cancer cell line was treated with two widely used PSs, aminolevulinic acid and verteporfin, using the LED modules at a clinically relevant 50  J  /  cm2 light dose that induced over 90% cell death for each treatment.

conclusionsOur work provides the community with a tool for new PS and multi-PS benchtop photodynamic research that, unlike most commercial light sources, affords the user a low barrier to entry and low-cost-per-wavelength with the goal of illuminating new insights at the forefront of PDT.

Indexed as

PhotochemotherapyAminolevulinic AcidCell LineLightingPhotosensitizing AgentsAminolevulinic AcidPhotosensitizing Agentsaminolevulinic acidbenzoporphyrin derivativelight-emitting diodesphotodynamic therapyverteporfin

Identifiers

PMID32297489
PMCPMC7156854
OpenAlexW3016991007

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.